• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤代谢:癌症治疗的新机遇

Tumor metabolism: new opportunities for cancer therapy.

作者信息

Mérida Isabel, Avila-Flores Antonia

机构信息

Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain.

出版信息

Clin Transl Oncol. 2006 Oct;8(10):711-6. doi: 10.1007/s12094-006-0117-6.

DOI:10.1007/s12094-006-0117-6
PMID:17074669
Abstract

Mammalian cells depend on extracellular input for the regulation of growth, proliferation and survival. Cancer cells evade these requirements, and are able to take up nutrients in a cell-autonomous fashion, which allows continuous growth and proliferation. To fulfill the high bioenergetic demands imposed by transformation, tumors must develop alternative mechanisms of energy production. Accordingly, the biochemical signature of cancer cells involves a shift to aerobic glycolysis, also known as the "Warburg effect". This property of cancer cells has resulted of great utility in modern medicine for detection of early tumors by positron-emission scanning. Nonetheless, the underlying mechanisms and contribution of the Warburg effect to the malignant phenotype have remained obscure. Thanks to recent advances in cancer research, we are beginning to understand the link between cancer genetics and the abnormal use of glucose by tumors. A new scenario is thus emerging, in which bioenergetics would contribute to and sustain malignant transformation. These findings are not only important for a better understanding of tumorigenesis; tumor reliance on glycolysis can be exploited in the search for novel, more potent therapeutic approaches to cancer treatment.

摘要

哺乳动物细胞依赖细胞外信号来调节生长、增殖和存活。癌细胞规避了这些需求,能够以细胞自主的方式摄取营养物质,从而实现持续生长和增殖。为了满足转化所带来的高生物能量需求,肿瘤必须发展出替代的能量产生机制。因此,癌细胞的生化特征涉及向有氧糖酵解的转变,也称为“瓦伯格效应”。癌细胞的这一特性在现代医学中对于通过正电子发射扫描检测早期肿瘤具有很大的实用价值。尽管如此,瓦伯格效应的潜在机制及其对恶性表型的贡献仍然不清楚。由于癌症研究的最新进展,我们开始理解癌症遗传学与肿瘤对葡萄糖的异常利用之间的联系。因此,一个新的情况正在出现,即生物能量学可能有助于并维持恶性转化。这些发现不仅对于更好地理解肿瘤发生很重要;肿瘤对糖酵解的依赖可用于寻找新的、更有效的癌症治疗方法。

相似文献

1
Tumor metabolism: new opportunities for cancer therapy.肿瘤代谢:癌症治疗的新机遇
Clin Transl Oncol. 2006 Oct;8(10):711-6. doi: 10.1007/s12094-006-0117-6.
2
Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K.癌症代谢与瓦伯格效应:缺氧诱导因子-1(HIF-1)和磷脂酰肌醇-3-激酶(PI3K)的作用
Mol Biol Rep. 2015 Apr;42(4):841-51. doi: 10.1007/s11033-015-3858-x.
3
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy.肿瘤中的甜蜜陷阱:有氧糖酵解及其潜在治疗靶点
Oncotarget. 2016 Jun 21;7(25):38908-38926. doi: 10.18632/oncotarget.7676.
4
Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.抑制有氧糖酵解可抑制Akt/mTOR/HIF-1α轴并恢复抗雌激素耐药乳腺癌细胞对他莫昔芬的敏感性。
PLoS One. 2015 Jul 9;10(7):e0132285. doi: 10.1371/journal.pone.0132285. eCollection 2015.
5
Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia.癌症中的有氧糖酵解:氧反应性基因和氟脱氧葡萄糖-PET作为组织缺氧标志物的可用性的意义。
Int J Cancer. 2008 Jun 15;122(12):2726-34. doi: 10.1002/ijc.23449.
6
Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis.Akt是“瓦伯格激酶”吗?——Akt与能量代谢的相互作用及肿瘤发生
Semin Cancer Biol. 2009 Feb;19(1):25-31. doi: 10.1016/j.semcancer.2008.11.010. Epub 2008 Dec 14.
7
[Therapeutic strategies targeting cancer--specific metabolism].针对癌症特异性代谢的治疗策略
Nihon Rinsho. 2015 Aug;73(8):1296-301.
8
Post-translational modifications and the Warburg effect.翻译后修饰与瓦伯格效应。
Oncogene. 2014 Aug 21;33(34):4279-85. doi: 10.1038/onc.2013.406. Epub 2013 Oct 7.
9
Metabolic phenotype of bladder cancer.膀胱癌的代谢表型。
Cancer Treat Rev. 2016 Apr;45:46-57. doi: 10.1016/j.ctrv.2016.03.005. Epub 2016 Mar 8.
10
The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?突变型RAS的贪婪特性:对靶向癌症代谢的药物发现是福音吗?
Acta Biochim Biophys Sin (Shanghai). 2016 Jan;48(1):17-26. doi: 10.1093/abbs/gmv102. Epub 2015 Oct 19.

引用本文的文献

1
A Missense Variant in Associated with Severe Neurodevelopmental Delay and Epilepsy.与严重神经发育迟缓及癫痫相关的一个错义变异。
Biomedicines. 2022 Dec 7;10(12):3171. doi: 10.3390/biomedicines10123171.
2
Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous F-FDG-PET/MRI for Tumor Delineation in Head and Neck Cancer?钆增强 MRI 序列在头颈部肿瘤 F-FDG-PET/MRI 融合成像中勾画靶区是否必要?
AJNR Am J Neuroradiol. 2020 Oct;41(10):1888-1896. doi: 10.3174/ajnr.A6764. Epub 2020 Sep 24.
3
Biological correlates of tumor perfusion and its heterogeneity in newly diagnosed breast cancer using dynamic first-pass F-FDG PET/CT.

本文引用的文献

1
Current development of mTOR inhibitors as anticancer agents.mTOR抑制剂作为抗癌药物的当前进展。
Nat Rev Drug Discov. 2006 Aug;5(8):671-88. doi: 10.1038/nrd2062.
2
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.磷脂酰肌醇3激酶作为生长和代谢调节因子的演变
Nat Rev Genet. 2006 Aug;7(8):606-19. doi: 10.1038/nrg1879.
3
TOR signaling in growth and metabolism.生长与代谢中的TOR信号传导
使用动态首过F-FDG PET/CT评估新诊断乳腺癌中肿瘤灌注及其异质性的生物学相关性
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1103-1115. doi: 10.1007/s00259-019-04422-4. Epub 2019 Aug 8.
4
Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma.转谷氨酰胺酶2:肾细胞癌致癌介质中的大师
Med Sci (Basel). 2019 Feb 6;7(2):24. doi: 10.3390/medsci7020024.
5
Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes.在非小细胞肺癌治疗中使用 EGFR-TKI 的联合策略:从临床前结果与临床结局之间的差距中学习。
Int J Biol Sci. 2018 Feb 5;14(2):204-216. doi: 10.7150/ijbs.22955. eCollection 2018.
6
Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma.在维持免疫耐受的同时进行共抑制阻断:胶质母细胞瘤的检查点抑制剂
Immunol Rev. 2017 Mar;276(1):9-25. doi: 10.1111/imr.12529.
7
Metabolism-related enzyme alterations identified by proteomic analysis in human renal cell carcinoma.通过蛋白质组学分析在人肾细胞癌中鉴定出的代谢相关酶改变。
Onco Targets Ther. 2016 Mar 9;9:1327-37. doi: 10.2147/OTT.S91953. eCollection 2016.
8
Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?迈向统一的儿科 18F-FDG PET/MR 方案:钆螯合物的给药是否必要?
J Nucl Med. 2016 Jan;57(1):70-7. doi: 10.2967/jnumed.115.161646. Epub 2015 Oct 15.
9
Proton pump inhibitors for the treatment of cancer in companion animals.用于治疗伴侣动物癌症的质子泵抑制剂。
J Exp Clin Cancer Res. 2015 Sep 4;34(1):93. doi: 10.1186/s13046-015-0204-z.
10
Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer.HSulf-1 的缺失促进卵巢癌中脂质代谢的改变。
Cancer Metab. 2014 Aug 18;2:13. doi: 10.1186/2049-3002-2-13. eCollection 2014.
Cell. 2006 Feb 10;124(3):471-84. doi: 10.1016/j.cell.2006.01.016.
4
AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.AMP激活的蛋白激酶:古老的能量计量器为现代新陈代谢理解提供线索
Cell Metab. 2005 Jan;1(1):15-25. doi: 10.1016/j.cmet.2004.12.003.
5
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.AMP激活的蛋白激酶诱导p53依赖的代谢检查点。
Mol Cell. 2005 Apr 29;18(3):283-93. doi: 10.1016/j.molcel.2005.03.027.
6
Multifaceted roles of glycolytic enzymes.糖酵解酶的多方面作用。
Trends Biochem Sci. 2005 Mar;30(3):142-50. doi: 10.1016/j.tibs.2005.01.005.
7
Glycolytic enzymes can modulate cellular life span.糖酵解酶可调节细胞寿命。
Cancer Res. 2005 Jan 1;65(1):177-85.
8
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.琥珀酸通过抑制缺氧诱导因子-α脯氨酰羟化酶,将三羧酸循环功能障碍与肿瘤发生联系起来。
Cancer Cell. 2005 Jan;7(1):77-85. doi: 10.1016/j.ccr.2004.11.022.
9
Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak.在有或没有Bax和Bak的情况下,由Akt介导的己糖激酶-线粒体相互作用是抑制细胞凋亡所必需的。
Mol Cell. 2004 Dec 3;16(5):819-30. doi: 10.1016/j.molcel.2004.11.014.
10
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.REDD1和TSC1/TSC2肿瘤抑制复合物对缺氧状态下mTOR功能的调控
Genes Dev. 2004 Dec 1;18(23):2893-904. doi: 10.1101/gad.1256804. Epub 2004 Nov 15.